arrow_back Back to App

Universal Coronavirus Vaccine Research: New Funding

This act allocates funds for further research into creating a universal coronavirus vaccine. The goal is to enhance public health security by developing more effective and long-lasting solutions in the fight against the virus.
Key points
Securing funding for research into a universal coronavirus vaccine.
Allocating $250 million annually for this purpose from 2021 through 2024.
Potentially enhancing public health protection and resilience against future virus variants.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_286
Sponsor: Sen. Markey, Edward J. [D-MA]
Process start date: 2021-02-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Coronavirus Vaccine Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_286.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-02-08.

What are the main provisions?

Key points include:

  • Securing funding for research into a universal coronavirus vaccine.
  • Allocating $250 million annually for this purpose from 2021 through 2024.
  • Potentially enhancing public health protection and resilience against future virus variants.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Markey, Edward J. [D-MA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health Public Investments